WAM
EDIT icon

Wolverine Asset Management’s Editas Medicine EDIT Stock Holding History

Wolverine Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-687
Closed -$19K – 1699
2020
Q3 		$19K Buy
+687
New +$22.4K ﹤0.01% 1406

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Wolverine Asset Management's EDIT Position: Q4 2020 in Review

Wolverine Asset Management sold out of Editas Medicine (EDIT) in Q4 2020, closing a stake of 687 shares — an estimated $19K sold.

Wolverine Asset Management first reported a position in EDIT in Q3 2020 and held it in 1 quarter. The position peaked at $19K in Q3 2020. 311 funds tracked by Wall St. Rank hold EDIT as of Q4 2020.

  • Wolverine Asset Management reported no remaining Editas Medicine position as of Q4 2020 after selling out during the quarter.
  • Wolverine Asset Management sold 687 Editas Medicine shares in Q4 2020, an estimated $19K.
  • Wolverine Asset Management first reported a position in Editas Medicine in Q3 2020 and held it in 1 quarter.
  • Wolverine Asset Management's Editas Medicine position peaked at $19K in Q3 2020.
  • 311 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2020.

Based on Wolverine Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.